Mr Russell Hirsch, MD PhD
Managing Director of Prospect Venture Partners. Prior to establishing Prospect Venture Partners II, was a member of the Health Care Technology Group at Mayfield. He joined Mayfield in 1992, served as a Venture Partner from 1993 to 1994 and as a General Pa
Serves or has served on the Board of Directors of Intuitive Surgical (NASDAQ: ISRG), Sunesis, Valentis (NASDAQ: VLTS), Opus Medical, Orquest (NASDAQ: JNJ), Infinity Pharmaceuticals, Genpath, Hansen Medical and several other privately-held companies. Russe
Holds an MD and PhD in Biochemistry from the University of California, San Francisco and a BA in Chemistry from the University of Chicago.
Venture capital firm
PSEPS ID: 26263